By admin 
The recent premiere of Nathan Fielder’s latest documentary, You Can See Everything, centered on the infamous figure of Elizabeth Holmes, has immediately captivated audiences and critics, with initial reactions describing it as a "bizarre three-hour masterpiece." The film, a significant addition to the growing canon of works dissecting the Theranos scandal, promises a distinct and deeply analytical perspective, particularly highlighting "human beings’ heartrending fallibility and infinite ego." This examination comes at a crucial time, as public discourse continues to grapple with the ethics of innovation, the cult of personality in Silicon Valley, and the complexities of accountability.
The Enigma of Elizabeth Holmes and the Rise and Fall of Theranos
To fully appreciate the context of Fielder’s documentary, it is essential to revisit the extraordinary trajectory of Elizabeth Holmes and her ill-fated blood-testing company, Theranos. Holmes, a Stanford University dropout, founded Theranos in 2003 with the ambitious vision of revolutionizing healthcare. Her promise was revolutionary: a proprietary technology, encapsulated in a device named "Edison," that could perform a vast array of blood tests using only a few drops of blood obtained from a finger-prick, rather than traditional venipuncture. This innovation, she claimed, would make blood testing faster, cheaper, and more accessible, empowering individuals to monitor their health proactively.
Holmes quickly ascended to celebrity status within the tech world. With her distinctive deep voice, black turtlenecks (a deliberate nod to Steve Jobs), and compelling narrative of democratizing healthcare, she garnered immense media attention and attracted a formidable roster of investors and board members. These included influential figures such as former Secretaries of State George Shultz and Henry Kissinger, former Secretary of Defense James Mattis, and media mogul Rupert Murdoch. By 2014, Theranos was valued at an astounding $9 billion, making Holmes, then 30, the youngest self-made female billionaire. The company partnered with major retailers like Walgreens and Safeway, planning to roll out its mini-labs across the nation.
However, the scientific community harbored skepticism about Theranos’s claims, which were largely shrouded in secrecy. The unraveling began in earnest in 2015 when investigative journalist John Carreyrou of The Wall Street Journal published a series of bombshell articles. Carreyrou’s reporting exposed that Theranos’s technology was largely fraudulent, incapable of performing the tests it claimed, and that the company was secretly using conventional commercial machines for most of its analyses. These revelations triggered a cascade of regulatory investigations, civil lawsuits, and criminal charges.
The Centers for Medicare & Medicaid Services (CMS) found Theranos’s California lab posed "immediate jeopardy to patient health and safety" in 2016, ultimately revoking its license. The company was forced to void tens of thousands of blood test results. In 2018, the U.S. Securities and Exchange Commission (SEC) charged Holmes and former Theranos President Ramesh "Sunny" Balwani with massive fraud, alleging they had engaged in an elaborate, years-long scheme to deceive investors. Holmes settled with the SEC, paying a $500,000 fine, relinquishing control of Theranos, and being barred from serving as an officer or director of a public company for 10 years.
The legal battles culminated in a highly publicized criminal trial. In January 2022, a jury found Holmes guilty on four counts of defrauding investors, though she was acquitted on charges related to defrauding patients. She was sentenced to 11 years and three months in prison, beginning her incarceration in May 2023 at FPC Bryan, a federal prison camp in Texas. The story of Elizabeth Holmes and Theranos remains a potent cautionary tale, emblematic of the darker side of Silicon Valley’s relentless pursuit of disruption and its often-unregulated culture of hype. The public’s enduring fascination stems from the sheer scale of the deception, the audacious ambition of its architect, and the fundamental questions it raises about trust, innovation, and ethical responsibility in the digital age.
Nathan Fielder’s Signature Approach to Storytelling
Nathan Fielder is renowned for his distinctive and often disquieting brand of comedic and documentary filmmaking. His previous works, most notably Nathan for You and The Rehearsal, have established him as a master of blurring the lines between reality and staged performance, social experiment, and meticulous meta-commentary. In Nathan for You, Fielder played a fictionalized version of himself, a business consultant offering absurd and elaborate strategies to struggling small businesses, often leading to profoundly awkward and revealing human interactions. His deadpan delivery and willingness to push social boundaries became hallmarks of his style.
The Rehearsal, which premiered in 2022, escalated his methodology to new heights. In this series, Fielder meticulously helped individuals "rehearse" difficult conversations or life events by constructing elaborate simulations, complete with trained actors and detailed sets. The show delved into profound philosophical questions about free will, authenticity, and the human desire for control, often with Fielder himself becoming deeply enmeshed in the simulated realities. His work is characterized by its uncomfortable authenticity, its exploration of human psychology under duress, and its tendency to provoke viewers into questioning the nature of truth and performance.
Given this background, Fielder’s decision to tackle the Elizabeth Holmes saga in You Can See Everything is particularly intriguing. His approach is rarely straightforward; instead of merely recounting facts, he often constructs narratives that reveal deeper, sometimes unsettling, truths about human behavior. His films are less about providing definitive answers and more about exploring the intricate, often contradictory, facets of the human experience. For a subject as complex and multi-layered as Elizabeth Holmes, whose public persona and private actions were starkly divergent, Fielder’s unique lens promises an unconventional exploration that moves beyond simple villainization or redemption narratives. The "bizarre" nature described in initial reactions aligns perfectly with his established modus operandi, suggesting that viewers should anticipate a documentary that challenges traditional forms and expectations.
"You Can See Everything": A Deep Dive into the Unconventional
The title itself, You Can See Everything, carries multiple layers of potential meaning, especially when applied to Elizabeth Holmes. It could allude to the deceptive promise of Theranos’s technology—the ability to "see everything" about one’s health from a single drop of blood. It might also refer to the eventual exposure of Holmes’s fraud, where "everything" became visible to the public and legal authorities. Moreover, in the context of Fielder’s filmmaking, it could imply an attempt to fully expose the psychological landscape of Holmes, or even a meta-commentary on the documentary’s own comprehensive, perhaps intrusive, gaze.
The description of the film as a "three-hour masterpiece" suggests a thorough, unhurried examination, allowing Fielder’s characteristic depth and slow-burn reveals to unfold. Unlike conventional true-crime documentaries that often prioritize a chronological recounting of events or the pursuit of definitive answers, You Can See Everything is likely to delve into the psychological underpinnings of Holmes’s actions and the broader societal forces that enabled her rise. Fielder’s use of re-enactments, carefully orchestrated social experiments, or even his own direct, often awkward, interactions with subjects could offer a starkly different perspective on Holmes’s motivations, her self-perception, and the dynamics of power and influence that characterized Theranos.
The primary takeaway cited by early viewers—that "human beings are fascinating in their heartrending fallibility and infinite ego"—provides a critical insight into the documentary’s thematic core. This indicates that Fielder is not merely interested in the factual recounting of fraud, but in the deeper, more universal aspects of human nature that drove Holmes. The "infinite ego" speaks to the grand ambition, self-belief, and perhaps self-deception that allowed Holmes to persist in her claims despite overwhelming evidence to the contrary. The "heartrending fallibility" suggests an exploration of the vulnerabilities, pressures, and perhaps even tragic elements that contributed to her downfall. Fielder’s films often evoke a sense of empathy for even the most flawed characters, not to excuse their actions, but to understand the human condition that underpins them. This nuanced approach promises a documentary that is both intellectually stimulating and emotionally resonant, challenging viewers to confront uncomfortable truths about ambition, ethics, and the capacity for self-delusion in themselves and society at large.
A Chronology of Deception and Downfall: The Theranos Timeline
The narrative of Elizabeth Holmes and Theranos spans nearly two decades, a detailed timeline of which is crucial for understanding the full scope of the scandal and the subject of Fielder’s documentary.
- 2003: Elizabeth Holmes drops out of Stanford University at age 19 to found Real-Time Cures, later renamed Theranos (a portmanteau of "therapy" and "diagnosis").
- Mid-2000s: Theranos secures initial funding from prominent investors, including Donald Lucas and Draper Fisher Jurvetson. Holmes begins cultivating relationships with influential figures.
- 2010: Theranos moves into a new headquarters in Palo Alto, California, and establishes its highly secretive culture.
- 2013: Theranos announces a partnership with Walgreens to open "Wellness Centers" in stores, promising convenient and affordable blood tests. The company’s valuation begins to soar.
- 2014: Theranos is valued at $9 billion, and Elizabeth Holmes is hailed as a visionary, gracing the covers of Forbes and Fortune magazines.
- February 2015: The New Yorker publishes a glowing profile of Holmes, further cementing her public image as a groundbreaking entrepreneur.
- October 2015: John Carreyrou of The Wall Street Journal publishes his first exposé, reporting that Theranos’s Edison machines are flawed and the company is using traditional machines for most tests. This marks the beginning of the public unraveling.
- December 2015: Federal regulators from the Centers for Medicare & Medicaid Services (CMS) find significant deficiencies at Theranos’s Newark, California, laboratory.
- January 2016: CMS threatens to revoke Theranos’s operating license and ban Holmes from owning or operating a blood-testing lab for two years.
- May 2016: Walgreens terminates its partnership with Theranos, closing all Wellness Centers.
- July 2016: CMS officially revokes Theranos’s lab license and imposes sanctions. The company voids two years of blood test results.
- April 2017: Theranos announces it will cease all lab operations and close its Wellness Centers.
- March 2018: The SEC charges Holmes and Balwani with massive fraud. Holmes agrees to a settlement, including a $500,000 fine and a ban from leadership roles in public companies for a decade.
- June 2018: A federal grand jury indicts Holmes and Balwani on wire fraud and conspiracy to commit wire fraud.
- September 2018: Theranos officially dissolves.
- August 2021 – January 2022: Elizabeth Holmes’s criminal trial takes place.
- January 3, 2022: Holmes is found guilty on four counts of defrauding investors and not guilty on four counts related to defrauding patients. The jury deadlocks on three other charges.
- November 18, 2022: Holmes is sentenced to 11 years and three months in prison, plus three years of supervised release.
- May 30, 2023: Elizabeth Holmes reports to FPC Bryan to begin her prison sentence.
- Current (Implied): Nathan Fielder’s You Can See Everything is released, offering a new cultural lens on this extensively documented saga.
Critical Reception and Public Discourse
The release of You Can See Everything is poised to ignite significant critical discussion and public debate. Fielder’s reputation for unconventional storytelling means critics will likely scrutinize not only the documentary’s factual accuracy but also its artistic merit, its ethical implications in portraying a convicted felon, and its broader contributions to the true-crime genre. Given the widespread coverage of Holmes’s story—including Alex Gibney’s HBO documentary The Inventor: Out for Blood in Silicon Valley and Hulu’s dramatic series The Dropout starring Amanda Seyfried—Fielder’s film enters a crowded field. Its success will depend on its ability to offer truly fresh insights and a distinctive perspective that transcends previous interpretations.
Anticipated critical reactions might range from high praise for Fielder’s bold artistic vision and his ability to excavate deeper psychological truths, to potential criticism regarding his characteristic manipulation of reality. Some critics might question whether Fielder’s meta-narrative style is appropriate for a subject with such severe real-world consequences, or if it risks inadvertently humanizing a figure convicted of serious fraud. However, others will likely laud his courage in challenging traditional documentary forms, using his unique methodology to explore the nuances of human behavior in a way that conventional narratives cannot.
Public discourse is also expected to be fervent. Elizabeth Holmes remains a polarizing figure, embodying both the promise and peril of Silicon Valley ambition. Fielder’s documentary will undoubtedly fuel conversations about accountability in the tech industry, the role of media in creating and dismantling public figures, and the inherent human fascination with stories of grand ambition and moral collapse. Viewers, accustomed to Fielder’s blurring of lines, may actively engage in deciphering the "truth" presented, questioning the authenticity of every scene and interaction, a dynamic that Fielder himself often encourages. The film’s ability to spark such intense engagement, forcing audiences to think critically about the narrative construction itself, will be a testament to its impact.
Broader Implications: Silicon Valley, Ethics, and the Art of Documentary
You Can See Everything is more than just another retelling of the Elizabeth Holmes story; it represents a significant cultural artifact that speaks to several broader societal implications. Firstly, it contributes to the ongoing critique of Silicon Valley’s pervasive "fake it ’til you make it" culture. The Theranos saga laid bare the dangers of prioritizing hype and investor confidence over scientific rigor and ethical conduct. Fielder’s exploration of "infinite ego" within this context could offer profound insights into how personal ambition, unchecked by accountability, can lead to widespread deception and harm. The documentary may further highlight the systemic issues within the venture capital ecosystem that allowed Theranos to thrive for so long, insulated from scrutiny by its powerful board and investors.
Secondly, the film pushes the boundaries of documentary filmmaking as an art form. Nathan Fielder’s work consistently challenges traditional notions of objectivity and factual presentation, opting instead for a more experiential and often provocative approach. By tackling a subject as sensitive and well-documented as Elizabeth Holmes, Fielder forces audiences to reconsider what they expect from a documentary. Is its purpose solely to inform, or can it also be to evoke, to provoke, and to dismantle preconceived notions through unconventional narrative strategies? You Can See Everything will likely become a case study in the evolving ethics of documentary, particularly when filmmakers actively shape or influence the realities they present.
Finally, the enduring human fascination with stories of grand ambition, deception, and moral collapse finds a compelling new outlet in Fielder’s work. The tale of Elizabeth Holmes taps into universal themes of aspiration, failure, and the complex interplay between charisma and manipulation. By focusing on "heartrending fallibility," the documentary may offer a more humanized, albeit not exculpatory, portrait of Holmes, inviting viewers to grapple with the complexities of her motivations rather than simply condemning her actions. This nuanced approach has the potential to deepen public understanding of the psychological dimensions of white-collar crime and the immense pressure cooker environment of high-stakes entrepreneurship.
In conclusion, Nathan Fielder’s You Can See Everything is poised to be a landmark documentary, not just for its subject matter, but for its groundbreaking approach to storytelling. By applying his unique, often unsettling, cinematic methodology to the saga of Elizabeth Holmes, Fielder promises a film that transcends mere factual recounting. Instead, it offers a deep dive into the "heartrending fallibility and infinite ego" that defined Theranos’s rise and fall, forcing viewers to reflect on the ethical landscape of innovation, the complexities of human nature, and the very art of seeing and understanding truth in a world increasingly blurred by performance and perception. The documentary stands as a crucial cultural commentary, inviting sustained critical engagement and re-evaluation of a pivotal moment in contemporary history.
